Progress in Cardiovascular Diseases

Journal

Publication Venue For

  • Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.  75:78-82. 2022
  • Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension.  73:17-23. 2022
  • Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system.  71:86-91. 2022
  • Income disparity and incident cardiovascular disease in older Americans.  71:92-99. 2022
  • Body and Fat mass are not Regulated, Controlled, or Defended: An introduction to the Invisible Hand’ and ‘Competition’ Models of Metabolism 2022
  • Hybrid cardiac rehabilitation – The state of the science and the way forward.  70:175-182. 2022
  • Physical activity trends and metabolic health outcomes in people living with HIV in the US, 2008–2015.  63:170-177. 2020
  • Implications for REDUCE IT in clinical practice.  62:395-400. 2019
  • The Contributions of ‘Diet’ ‘Genes’ and Physical Activity to the Etiology of Obesity: Contrary Evidence and Consilience.  61:89-102. 2018
  • The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.  58:69-75. 2015
  • Lipid-lowering therapy in patients 75 years and older: Clinical priority or superfluous therapy?.  57:187-196. 2014
  • Sudden Cardiac Death and Preparticipation Screening: The Debate Continues-In Support of Electrocardiogram-Inclusive Preparticipation Screening.  54:445-450. 2012
  • Observational epidemiology within randomized clinical trials: Getting a lot for (almost) nothing.  54:367-371. 2012
  • Patient Awareness of the Risks for Heart Disease Posed by Air Pollution.  53:379-384. 2011
  • Sleep Apnea, Aldosterone, and Resistant Hypertension.  51:371-380. 2009
  • Skeletal Myoblasts as a Therapeutic Agent.  50:7-17. 2007
  • Left ventricular assist device-induced reverse ventricular remodeling.  43:19-26. 2000
  • Dietary salt reduction in hypertension - What is the evidence and why is it still controversial?.  42:23-38. 1999
  • Can indices of left ventricular function be applied to the right ventricle?.  40:309-324. 1998
  • Ventricular interdependence: Significant left ventricular contributions to right ventricular systolic function.  40:289-308. 1998
  • Cardiac catheterization and angiographic analysis computer applications.  25:409-434. 1983
  • Computer techniques for epicardial and endocardial mapping.  26:15-32. 1983
  • Ultrasonic assessment of transposition of the great vessels.  21:43-52. 1978

    • International Standard Serial Number (issn)

  • 0033-0620

    • Electronic International Standard Serial Number (eissn)

  • 1873-1740